Combining our experimental results with clinical data, we found that the MAPKAPK2 gene in peripheral blood is a potential biomarker for early diagnosis of PD because its expressed was changed immediately before pathological aggregation of α-Syn. Here, MAPKAPK2 is linked to Parkinson disease.